Literature DB >> 26944097

Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?

Pier Andrea Borea1, Stefania Gessi2, Stefania Merighi3, Katia Varani4.   

Abstract

The importance of adenosine for human health cannot be overstated. Indeed, this ubiquitous nucleoside is an integral component of ATP, and regulates the function of every tissue and organ in the body. Acting via receptor-dependent and -independent mechanisms [the former mediated via four G-protein-coupled receptors (GPCRs), A1, A2A, A2B, and A3,], it has a significant role in protecting against cell damage in areas of increased tissue metabolism, and combating organ dysfunction in numerous pathological states. Accordingly, raised levels of adenosine have been demonstrated in epilepsy, ischaemia, pain, inflammation, and cancer, in which its behaviour can be likened to that of a guardian angel, even though there are instances in which overproduction of adenosine is pathological. In this review, we condense the current body of knowledge on the issue, highlighting when, where, and how adenosine exerts its protective effects in both the brain and the periphery.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  adenosine; adenosine receptors; cancer; inflammation; ischaemia; pain

Mesh:

Substances:

Year:  2016        PMID: 26944097     DOI: 10.1016/j.tips.2016.02.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  94 in total

Review 1.  The Role of Adenosine Receptor Activation in Attenuating Cartilaginous Inflammation.

Authors:  Jonathan M Bekisz; Christopher D Lopez; Carmen Corciulo; Aranzazu Mediero; Paulo G Coelho; Lukasz Witek; Roberto L Flores; Bruce N Cronstein
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

2.  Multiple adenosine receptor subtypes stimulate wound healing in human EA.hy926 endothelial cells.

Authors:  Zeinab Bonyanian; Matthew Walker; Eugene Du Toit; Roselyn B Rose'Meyer
Journal:  Purinergic Signal       Date:  2019-06-28       Impact factor: 3.765

3.  Colorimetric adenosine aptasensor based on DNA cycling amplification and salt-induced aggregation of gold nanoparticles.

Authors:  Caiyun Kong; Linna Gao; Zhengbo Chen
Journal:  Mikrochim Acta       Date:  2018-10-02       Impact factor: 5.833

4.  Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters.

Authors:  Dilip K Tosh; Aaron Janowsky; Amy J Eshleman; Eugene Warnick; Zhan-Guo Gao; Zhoumou Chen; Elizabeth Gizewski; John A Auchampach; Daniela Salvemini; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2017-03-20       Impact factor: 7.446

5.  Adenosine A2a Receptor Blockade Diminishes Wnt/β-Catenin Signaling in a Murine Model of Bleomycin-Induced Dermal Fibrosis.

Authors:  Jin Zhang; Carmen Corciulo; Hailing Liu; Tuere Wilder; Mayumi Ito; Bruce Cronstein
Journal:  Am J Pathol       Date:  2017-06-28       Impact factor: 4.307

Review 6.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

7.  Endothelial adenosine kinase deficiency ameliorates diet-induced insulin resistance.

Authors:  Jiean Xu; Qiuhua Yang; Xiaoyu Zhang; Zhiping Liu; Yapeng Cao; Lina Wang; Yaqi Zhou; Xianqiu Zeng; Qian Ma; Yiming Xu; Yong Wang; Lei Huang; Zhen Han; Tao Wang; David Stepp; Zsolt Bagi; Chaodong Wu; Mei Hong; Yuqing Huo
Journal:  J Endocrinol       Date:  2019-08       Impact factor: 4.286

8.  A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.

Authors:  Seyyed Mehdi Jafari; Hamid Reza Joshaghani; Mojtaba Panjehpour; Mahmoud Aghaei
Journal:  Cell Oncol (Dordr)       Date:  2017-12-07       Impact factor: 6.730

9.  Activation of adenosine A2A or A2B receptors causes hypothermia in mice.

Authors:  Jesse Lea Carlin; Shalini Jain; Romain Duroux; R Rama Suresh; Cuiying Xiao; John A Auchampach; Kenneth A Jacobson; Oksana Gavrilova; Marc L Reitman
Journal:  Neuropharmacology       Date:  2018-03-13       Impact factor: 5.250

Review 10.  Purinergic signaling: a potential therapeutic target for depression and chronic pain.

Authors:  Yuting Zou; Runan Yang; Lin Li; Xiumei Xu; Shangdong Liang
Journal:  Purinergic Signal       Date:  2021-08-02       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.